AI Advances in Developing Drug-Like Antibodies: When Will Biopharma See a Breakthrough?

Artificial intelligence has reached a pivotal milestone by successfully creating drug-like antibodies, signaling a potential transformation in the biopharmaceutical industry. This breakthrough prompts the question: how soon will AI-driven antibody design revolutionize drug development and biopharma practices?